Statera Biopharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STAB and other ETFs, options, and stocks.

About STAB

Statera Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. Its proprietary product toll-like receptor (TLR) agonists in the biopharmaceutical industry with TLR4 and TLR9 antagonists, and the TLR5 agonists, Entolimod and GP532 have applications in mitigation of radiation injury and neutropenia an anemia. 

CEO
Michael Kevin Handley
CEOMichael Kevin Handley
Employees
Employees
Headquarters
Fort Collins, Colorado
HeadquartersFort Collins, Colorado
Founded
2003
Founded2003
Employees
Employees

STAB Key Statistics

Market cap
6.38M
Market cap6.38M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
316.73K
Average volume316.73K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$4.18
52 Week high$4.18
52 Week low
$0.111
52 Week low$0.111

STAB Earnings

-$0.47
-$0.31
-$0.16
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
per share
Estimated per share
Actual
Expected Oct 11, Pre-Market
ActualExpected Oct 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.